PKI stock forecast
Our latest prediction for PerkinElmer, Inc. (United States)'s stock price was made on the Aug. 2, 2018 when the stock price was at 86.55$.
In the short term (2weeks), PKI's stock price should underperform the market by -0.02%. During that period the price should oscillate between -3.54% and +2.97%.
In the medium term (3months), PKI's stock price should underperform the market by -0.23%. During that period the price should oscillate between -8.02% and +8.61%.Get email alerts
About PerkinElmer, Inc. (United States)
PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following two segments: Discovery & Analytical Solutions, and Diagnostics. The Discovery & Analytical Solutions segment comprises of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937 and is headquartered in Waltham, MA.
At the moment the company generates 2778M USD in revenues.
On its last earning announcement, the company reported a profit of 2.13$ per share.
The book value per share is 22.73$
Three months stock forecastAug. 2, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|